|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Premiums before ceded reinsurance | |||||
| Reinsurance premiums ceded | |||||
| Premium | |||||
| Investment income | |||||
| Other revenues | |||||
| Total revenue | |||||
| Operating Expenses | |||||
| Medical | |||||
| Other insurance costs | |||||
| Selling, general, and administrative | |||||
| Depreciation and amortization | |||||
| Federal and state assessments | |||||
| Premium deficiency reserve (release) | |||||
| Total operating expenses | |||||
| Earnings (loss) from operations | |||||
| Interest expense | |||||
| Other expenses | |||||
| Loss on extinguishment of debt | |||||
| Earnings (loss) before income taxes | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Less: Net income attributable to noncontrolling interests | |||||
| Net income (loss) attributable to Oscar Health, Inc. | |||||
| Earnings (Loss) per Share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted Average Common Shares Outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...